Molecular Screening and Therapeutics Study

Comprehensive genome profiling can identify a large number of variants in hundreds of genes that may be involved in driving cancer. This information allows researchers and clinicians to develop a precise treatment plan for each patient, that offers the best chance of a positive outcome, avoids expensive treatments that are unlikely to work or may have unwanted side effects

In future comprehensive genome profiling will be standard of care, but at the moment, for a variety of reasons, it is not readily available.

Now, eligible patients across south-eastern Victoria can access this service through the MPCCC Precision Oncology Program and by being part of a national research study.

Click on the links below to find out more about the study, and if you have further questions contact Sarah Mwaba on Sarah.Mwaba@monash.edu